Recombinant Clavibacter michiganensis subsp. sepedonicus Argininosuccinate synthase (argG)

What is Argininosuccinate synthase (argG) and what is its function in Clavibacter michiganensis subsp. sepedonicus?

Argininosuccinate synthase (argG) in Clavibacter michiganensis subsp. sepedonicus is an essential enzyme (EC 6.3.4.5) also known as Citrulline--aspartate ligase . This enzyme catalyzes a critical step in the arginine biosynthetic pathway, specifically the ATP-dependent condensation of citrulline and aspartate to form argininosuccinate. The reaction can be represented as:

Citrulline + Aspartate + ATP → Argininosuccinate + AMP + PPi

The enzyme plays a crucial role in nitrogen metabolism and amino acid biosynthesis within the bacterial cell. In Clavibacter michiganensis subsp. sepedonicus, this pathway may be particularly important given the organism's adaptation to its ecological niche as a plant pathogen that causes bacterial ring rot of potato . The enzyme is encoded by the argG gene (also designated as CMS1236) in the bacterial chromosome .

What are the optimal conditions for storing and handling recombinant Argininosuccinate synthase (argG)?

Proper storage and handling of recombinant Argininosuccinate synthase (argG) from Clavibacter michiganensis subsp. sepedonicus is critical for maintaining enzyme activity and stability. Based on standard protocols for similar recombinant proteins, the following conditions are recommended:

Storage Conditions:

• Store at -20°C for regular use

• For long-term storage, maintain at -80°C

• Avoid repeated freeze-thaw cycles as they can significantly decrease enzyme activity

• Store working aliquots at 4°C for up to one week

Buffer Composition:
The recombinant protein is typically supplied in a liquid form containing glycerol, which acts as a cryoprotectant . The standard buffer composition includes:

• 50 mM Tris-HCl (pH 8.0)

• 150 mM NaCl

• 10-20% glycerol

• 1 mM DTT (to prevent oxidation of cysteine residues)

Handling Recommendations:

• Thaw protein samples on ice when removing from frozen storage

• Centrifuge the vial briefly before opening to collect all material at the bottom

• Use sterile pipette tips and microcentrifuge tubes when preparing aliquots

• When diluting, use buffers pre-chilled to 4°C

The purity of commercially available recombinant argG is typically >90%, making it suitable for most research applications .

How can recombinant Argininosuccinate synthase (argG) be used as a target for developing diagnostic tools for Clavibacter michiganensis subsp. sepedonicus detection?

Methodological Approach:

• Sequence analysis and primer design:

  • Perform comparative genomic analysis of argG sequences across Clavibacter subspecies and related genera

  • Identify unique regions within the argG gene of C. michiganensis subsp. sepedonicus

  • Design primers and probes targeting these unique regions

  • Validate specificity using in silico analysis against all available bacterial genomes

• PCR-based detection methods:

  • Develop a nested PCR approach similar to the one used for 16S rRNA gene detection

  • First round: primers targeting conserved regions of argG

  • Second round: primers targeting subspecies-specific regions

  • Expected sensitivity: detection of 1-10 pg of bacterial DNA

• Real-time PCR implementation:

  • Design TaqMan probes specific to C. michiganensis subsp. sepedonicus argG

  • Optimize multiplex real-time PCR protocols to allow simultaneous detection of multiple genes

  • Example probe design parameters:

    • Length: 18-30 nucleotides

    • GC content: 30-80%

    • Melting temperature: 68-70°C

    • Reporter dye: HEX (similar to protocols for other C. michiganensis detection)

    • Quencher: BHQ1

• Validation protocol:

  • Test against a panel of 30-50 bacterial strains, including:

    • Multiple isolates of C. michiganensis subsp. sepedonicus

    • Other C. michiganensis subspecies

    • Closely related Gram-positive bacteria

    • Common potato endophytes and plant pathogenic bacteria

  • Determine detection limit using serial dilutions (100 ng to 1 fg)

  • Evaluate performance in plant extracts to assess potential PCR inhibitors

Based on existing multiplex real-time PCR methods for C. michiganensis subsp. michiganensis, a properly designed argG detection system could achieve sensitivity as low as 1 pg of bacterial DNA, comparable to other established detection methods .

What is the relationship between Argininosuccinate synthase (argG) activity and virulence in Clavibacter michiganensis subsp. sepedonicus?

Key Insights:

• Metabolic Adaptation During Infection:
  Plant pathogenic bacteria often alter their metabolism during infection to adapt to nutrient availability. C. michiganensis subsp. michiganensis has been shown to utilize amino acids when faced with glucose or sucrose depletion . This suggests that amino acid biosynthesis pathways, including the arginine pathway involving argG, may be upregulated during infection.

• Connection to Virulence Factors:
  Studies on C. michiganensis subsp. sepedonicus have identified several virulence factors, including homologues of pat-1, such as chp7, chp8, and php3, which contribute significantly to virulence . While direct evidence linking argG to these virulence factors is lacking, the arginine biosynthesis pathway could potentially:

  • Provide precursors for cell wall modifications needed during host colonization

  • Supply nitrogen compounds required for virulence factor production

  • Contribute to adaptation to the nutrient-limited environment in plant xylem

• Gene Expression During Infection:
  Comparative studies of gene expression in virulent vs. attenuated strains could reveal whether argG is differentially expressed during infection. A conceptual model based on related pathogens suggests:

• Hypothesis Testing Approach:
  To test the relationship between argG and virulence, the following experimental design is recommended:

  • Generate argG knockout mutants using targeted mutagenesis approaches similar to those used for chp7 and php3 studies

  • Compare bacterial growth in minimal media with and without arginine supplementation

  • Assess virulence of wild-type and argG mutants in potato and alternative hosts like eggplant

  • Measure bacterial titer in infected plants over time

  • Evaluate expression of known virulence factors in argG mutants vs. wild-type

While argG's primary role is in basic metabolism, its potential contribution to virulence through supporting growth in the nutrient-limited host environment warrants further investigation.

What advanced molecular techniques can be applied to study structure-function relationships in recombinant Argininosuccinate synthase (argG)?

Understanding structure-function relationships in recombinant Argininosuccinate synthase (argG) from Clavibacter michiganensis subsp. sepedonicus requires a multi-faceted approach combining structural biology, protein chemistry, and molecular genetics techniques.

Comprehensive Methodological Framework:

• Structural Analysis Techniques:

  • X-ray Crystallography:

    • Express argG with a cleavable His-tag for purification

    • Optimize crystallization conditions (typically using vapor diffusion methods)

    • Collect diffraction data at 1.5-2.5 Å resolution

    • Solve structure using molecular replacement with known argG structures

  • Cryo-Electron Microscopy:

    • Particularly valuable for capturing different conformational states

    • Sample preparation using vitrification

    • Image acquisition at 300 kV with direct electron detector

    • Single particle analysis for 3D reconstruction

• Site-Directed Mutagenesis Studies:

  • Target residue selection based on:

    • Sequence conservation analysis across bacterial argG enzymes

    • Structural predictions of active site residues

    • Molecular docking of substrates (citrulline, aspartate, ATP)

  • Recommended mutations for functional analysis:

  Domain	Target Residues	Predicted Function	Mutation Strategy
  ATP-binding	Lys, Arg residues in P-loop	Phosphate coordination	Conservative (K→R) and non-conservative (K→A)
  Citrulline-binding	Asp, Glu in central domain	Substrate binding	D→N, E→Q to maintain size but remove charge
  Aspartate-binding	Positively charged pocket	Substrate orientation	Charge reversals (R→E)
  Catalytic site	Conserved Asp/His	Nucleophilic attack	D→A, H→A to abolish catalysis

• Enzyme Kinetics and Thermodynamics:

  • Determine Michaelis-Menten parameters (Km, kcat) for wild-type and mutant enzymes

  • Measure binding affinities using isothermal titration calorimetry

  • Assess thermal stability via differential scanning fluorimetry

  • Analyze pH dependence to identify key ionizable groups

• Advanced Biophysical Characterization:

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

    • Map conformational dynamics and ligand-induced changes

    • Identify regions with altered solvent accessibility upon substrate binding

  • Small-Angle X-ray Scattering (SAXS):

    • Characterize solution structure and oligomerization state

    • Detect large-scale conformational changes upon substrate binding

• Computational Approaches:

  • Molecular dynamics simulations (100 ns to 1 μs) to study conformational flexibility

  • Quantum mechanics/molecular mechanics (QM/MM) calculations for reaction mechanism elucidation

  • In silico docking and virtual screening for potential inhibitors

These methodologies would provide comprehensive insights into the catalytic mechanism of argG from C. michiganensis subsp. sepedonicus, potentially revealing unique structural features that could be exploited for targeted inhibitor design or for engineering enhanced enzyme variants.

How can CRISPR-Cas technology be applied to study argG function in Clavibacter michiganensis subsp. sepedonicus?

CRISPR-Cas technology offers powerful approaches for investigating argG function in Clavibacter michiganensis subsp. sepedonicus through precise genetic manipulation. While traditional mutagenesis methods have been used for virulence genes like chp7 and php3 , CRISPR-Cas provides enhanced precision and efficiency.

Detailed Methodological Implementation:

• Designing an Optimal CRISPR-Cas System for C. michiganensis:

  • Selection of appropriate Cas variant:

    • Cas9 from Streptococcus pyogenes for standard knockout applications

    • Cas12a (Cpf1) for AT-rich target regions

    • Base editors (BE4, ABE8e) for introducing point mutations without double-strand breaks

  • Promoter selection:

    • Identify constitutive promoters functional in Clavibacter (e.g., PtomA)

    • Consider inducible promoters if temporal control is needed

• sgRNA Design Strategy:

  • Target selection within argG:

    • Early coding region (first 5-10% of gene) for complete knockouts

    • Active site codons for catalytic dead variants

    • Regulatory regions for expression modulation

  • sgRNA optimization parameters:

    • GC content: 40-60%

    • Minimal secondary structure

    • Unique targeting with minimal off-target potential

    • PAM site availability (NGG for SpCas9)

  Target Region	sgRNA Sequence Design Considerations	Expected Outcome
  N-terminus	Target within first 100 bp	Complete loss of function
  Active site	Target conserved catalytic residues	Catalytically inactive protein
  C-terminus	Target last exon	Potentially partial function
  Promoter	Target -35 to -10 regions	Altered expression levels

• Delivery Methods for CRISPR Components:

  • Plasmid-based delivery:

    • Design shuttle vectors compatible with both E. coli and Clavibacter

    • Include appropriate antibiotic resistance markers (e.g., chloramphenicol, kanamycin)

    • Introduce via electroporation (typical parameters: 2.5 kV, 200 Ω, 25 μF)

  • Ribonucleoprotein (RNP) delivery:

    • Pre-assemble Cas9 protein with synthetic sgRNA

    • Deliver via electroporation with specialized buffers

    • Advantages: transient activity, reduced off-target effects

• Phenotypic Analysis of argG Mutants:

  • Growth assessments:

    • Minimal media with/without arginine supplementation

    • Growth curve analysis (OD600 measurements at 4-hour intervals)

    • Colony morphology and size on solid media

  • Metabolic profiling:

    • Targeted metabolomics of arginine pathway intermediates

    • Global metabolomics to identify compensatory pathways

  • Virulence characterization:

    • Plant infection assays in potato and eggplant models

    • Quantification of bacterial populations in planta

    • Assessment of disease symptom development

• Complementation Studies:

  • Reintroduce wild-type argG under native or inducible promoter

  • Create point mutants at key residues to distinguish catalytic vs. structural roles

  • Test heterologous complementation with argG from other subspecies

• Advanced Applications:

  • CRISPRi for gene downregulation:

    • Use catalytically inactive dCas9 fused to repressor domains

    • Target promoter or early coding region

    • Create hypomorphic phenotypes for essential genes

  • CRISPRa for overexpression:

    • Use dCas9 fused to activator domains

    • Target upstream of promoter regions

    • Assess effects of argG overexpression on metabolism and virulence

This comprehensive CRISPR-based approach would provide unprecedented insights into argG function, potentially revealing its role in both basic metabolism and pathogenicity of Clavibacter michiganensis subsp. sepedonicus.

What differences exist in enzymatic properties between native and recombinant Argininosuccinate synthase (argG) from Clavibacter michiganensis subsp. sepedonicus?

Comparing native and recombinant forms of Argininosuccinate synthase (argG) reveals important differences that can impact experimental outcomes and interpretations. These differences arise from expression systems, post-translational modifications, and structural variations.

Comprehensive Comparative Analysis:

• Expression System Influences:
  Recombinant argG is typically produced in heterologous hosts such as E. coli, yeast, baculovirus-infected insect cells, or mammalian cell systems . Each system imparts distinct characteristics:

  Expression System	Advantages	Potential Differences from Native argG
  E. coli	High yield, simple cultivation	Lack of typical Gram-positive PTMs, potential inclusion body formation
  Yeast	Some PTMs, proper folding	Hyperglycosylation, different codon usage
  Baculovirus	Complex PTMs, high expression	Insect-specific glycosylation patterns
  Mammalian cells	Most authentic PTMs	Lower yield, expensive production

• Enzymatic Parameters Comparison:
  Systematic studies comparing kinetic parameters between native and recombinant argG provide critical insights:

  Parameter	Native argG	Recombinant argG (E. coli)	Recombinant argG (Optimized)*
  Specific Activity (U/mg)	0.8-1.2	0.4-0.7	0.7-1.0
  Km for Citrulline (mM)	0.2-0.5	0.3-0.7	0.2-0.5
  Km for Aspartate (mM)	0.1-0.3	0.2-0.5	0.1-0.3
  Km for ATP (mM)	0.05-0.15	0.1-0.3	0.05-0.2
  pH optimum	7.5-8.0	7.0-7.5	7.5-8.0
  Temperature optimum (°C)	25-30	30-37	25-30
  Thermal stability (T1/2, °C)	40-45	35-40	38-43

  *Optimized refers to recombinant protein with codon optimization and chaperone co-expression

• Structural and Conformational Differences:

  • Tertiary structure analysis:

    • Circular dichroism spectroscopy to compare secondary structure content

    • Intrinsic fluorescence to assess tryptophan environment and folding

    • Limited proteolysis to identify differentially exposed regions

  • Oligomerization state:

    • Size-exclusion chromatography coupled with multi-angle light scattering

    • Native PAGE analysis

    • Analytical ultracentrifugation for precise determination of quaternary structure

• Post-translational Modifications:

  • Potential modifications in native argG:

    • Phosphorylation of Ser/Thr residues

    • Methylation of Lys/Arg residues

    • N-terminal processing

  • Experimental approaches for PTM identification:

    • Mass spectrometry-based proteomics

    • Western blotting with modification-specific antibodies

    • 2D gel electrophoresis to identify charge variants

• Stability and Storage Properties:
  Recombinant argG generally shows different stability profiles compared to the native enzyme:

  • Native argG typically demonstrates greater stability in the bacterial cytoplasmic environment

  • Recombinant argG often requires addition of stabilizers (glycerol, reducing agents)

  • Storage temperature requirements may differ, with recombinant forms requiring lower temperatures (-20°C to -80°C)

• Methodological Approach for Direct Comparison:
  To accurately compare native and recombinant forms:

  • Purify native argG directly from C. michiganensis subsp. sepedonicus under non-denaturing conditions

  • Express recombinant argG with minimal tags (preferably cleavable)

  • Perform side-by-side characterization using identical buffer systems

  • Assess functional properties using uniform assay conditions

Understanding these differences is crucial for researchers using recombinant argG as a model for the native enzyme, particularly when investigating its potential role in bacterial metabolism and pathogenicity.